CBL

Minor cannabinoid

Cannabicyclol

A rare cannabinoid. A 2025 experimental study investigated its interaction with the serotonin 5-HT1A receptor. This does not demonstrate clinical efficacy or establish effects of the formulation.

01 / ADVANCED HEMP SCIENCE

What science investigates

Laboratory study

Cannabicyclol interaction with the serotonin 5-HT1A receptor.

Read the research · PubMed ↗

02 / CONTEXT

The scope of the evidence

Activity at a receptor does not demonstrate clinical benefit, safety of use or a treatment indication.

Studies of a compound do not establish the same effects in a commercial formula. Selection, dosage and follow-up belong with the prescriber.

GREENLION / PRECISION

Present in Precision profiles

GREENLION ReliefRelief ↗
Illustrative images and profiles. Plant-derived composition may vary between batches. Consult the COA for your product.Talk to your prescriber. Explore the Medical Area. ↗

LOT DOCUMENTATION

Consult the COA for GREENLION.

Choose the identification that matches the package. The certificate of analysis shows results for that specific lot.

Restricted accessSign in as a physician or patient to view certificates.
Documentation becomes available after account authentication and profile validation.